Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Comment by forhandlarenon Oct 04, 2022 2:26pm
123 Views
Post# 35004772

RE:Irrational meets rational

RE:Irrational meets rational 1) In theory I agree, but based on what's known about the two last deals we're in the dark and trust is low - hence the share price. Unknown timeline also speaks to it. The two first deals were pretty good, nailed by another CEO who's long gone.

2) I want Howard to confirm change of CEO, floating an idea via PRC Partners does not cut it, especially when they proved to be so wrong about the upfront.

The share price would double or triple if Howard announce his retirement! In fact, that could trigger sustainable and substantial higher share price.

3) Since the pet deal would include multiple partners there's a chance - in fact I demand it - that deal numbers could be communicated. But in general I don't see this 10x to materialize over night. They prioritize revenue streams down the road.

Surprise me, please!

4) In theory I agree, but what's the plan to finance the expansion? Dilution? French grants?

Communicate this to the market!
<< Previous
Bullboard Posts
Next >>